CPT2 (carnitine palmitoyltransferase 2) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: CPT2 (carnitine palmitoyltransferase 2) Homo sapiens
Analyze
Symbol: CPT2
Name: carnitine palmitoyltransferase 2
RGD ID: 736835
HGNC Page HGNC:2330
Description: Enables carnitine O-palmitoyltransferase activity. Involved in carnitine metabolic process; fatty acid beta-oxidation; and long-chain fatty acid metabolic process. Located in mitochondrion; nucleolus; and nucleoplasm. Implicated in brain disease; lipid metabolism disorder; and muscular disease.
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: carnitine O-palmitoyltransferase 2, mitochondrial; carnitine palmitoyltransferase II; CPT II; CPT1; CPTASE; IIAE4; testicular secretory protein Li 13
RGD Orthologs
Mouse
Rat
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Orthologs
More Info more info ...
Related Pseudogenes: CPT2P1  
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38153,196,824 - 53,214,197 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl153,196,792 - 53,214,197 (+)EnsemblGRCh38hg38GRCh38
GRCh37153,662,496 - 53,679,869 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36153,434,689 - 53,452,455 (+)NCBINCBI36Build 36hg18NCBI36
Build 34153,374,121 - 53,391,888NCBI
Celera151,949,941 - 51,967,712 (+)NCBICelera
Cytogenetic Map1p32.3NCBI
HuRef151,777,752 - 51,795,523 (+)NCBIHuRef
CHM1_1153,779,095 - 53,796,864 (+)NCBICHM1_1
T2T-CHM13v2.0153,078,266 - 53,095,633 (+)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-beta-thujone  (EXP)
(+)-dexrazoxane  (ISO)
(R)-camphor  (EXP)
(R)-carnitine  (EXP,ISO)
(R)-linalyl acetate  (EXP)
(S)-colchicine  (EXP)
1,1-dichloroethene  (ISO)
1,2-dimethylhydrazine  (ISO)
1,4-benzoquinone  (EXP)
1,8-cineole  (EXP)
1-naphthyl isothiocyanate  (ISO)
17alpha-ethynylestradiol  (ISO)
17beta-estradiol  (EXP,ISO)
2,2',4,4',5,5'-hexachlorobiphenyl  (ISO)
2,2,2-tetramine  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (ISO)
2,4,6-tribromophenol  (EXP)
2,4-dinitrotoluene  (ISO)
2-hydroxypropanoic acid  (EXP)
3,3',4,4',5-pentachlorobiphenyl  (ISO)
3,3',5,5'-tetrabromobisphenol A  (EXP)
3,4-methylenedioxymethamphetamine  (ISO)
3,5-diethoxycarbonyl-1,4-dihydrocollidine  (ISO)
3-chloropropane-1,2-diol  (ISO)
3-isobutyl-1-methyl-7H-xanthine  (ISO)
6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime  (EXP)
acetamide  (ISO)
adenine  (EXP)
Aescin  (EXP,ISO)
aflatoxin B1  (ISO)
aldehydo-D-glucose  (ISO)
all-trans-retinoic acid  (EXP)
allopurinol  (ISO)
amiodarone  (ISO)
ammonium chloride  (ISO)
aristolochic acid A  (ISO)
ATP  (EXP)
atrazine  (EXP)
azoxystrobin  (ISO)
benzo[a]pyrene  (EXP,ISO)
bexarotene  (ISO)
bezafibrate  (EXP,ISO)
bis(2-ethylhexyl) phthalate  (ISO)
bisphenol A  (EXP,ISO)
Bisphenol B  (EXP)
bisphenol F  (EXP)
Brodifacoum  (ISO)
buspirone  (ISO)
Butylbenzyl phthalate  (ISO)
cadmium atom  (ISO)
cadmium dichloride  (ISO)
camphor  (EXP)
carbamazepine  (EXP)
carbon nanotube  (ISO)
CGP 52608  (EXP)
chlorpyrifos  (ISO)
ciprofibrate  (ISO)
cisplatin  (EXP)
clofibrate  (ISO)
clofibric acid  (ISO)
clozapine  (ISO)
copper(II) sulfate  (EXP)
corn oil  (ISO)
cyclosporin A  (EXP)
cyproconazole  (ISO)
D-glucose  (ISO)
decabromodiphenyl ether  (ISO)
dexamethasone  (ISO)
Di-n-octyl phthalate  (ISO)
Dibutyl phosphate  (EXP)
dibutyl phthalate  (ISO)
dichloroacetic acid  (ISO)
diethyl phthalate  (ISO)
Diisodecyl phthalate  (ISO)
diisononyl phthalate  (ISO)
Diosbulbin B  (ISO)
dipentyl phthalate  (ISO)
diquat  (ISO)
diuron  (ISO)
doxorubicin  (EXP,ISO)
epoxiconazole  (ISO)
ethanol  (EXP)
ethyl methanesulfonate  (EXP)
etoposide  (EXP)
fenofibrate  (EXP,ISO)
fenthion  (ISO)
finasteride  (ISO)
fipronil  (EXP)
fluoranthene  (ISO)
flutamide  (ISO)
folic acid  (ISO)
formaldehyde  (EXP)
gemfibrozil  (ISO)
gentamycin  (ISO)
Gingerenone A  (ISO)
glafenine  (ISO)
glucose  (ISO)
glyphosate  (ISO)
gold atom  (EXP)
gold(0)  (EXP)
GW 4064  (EXP)
GW 7647  (EXP)
hexadecanoic acid  (EXP)
hydrazine  (ISO)
hydrogen peroxide  (ISO)
hydroxyurea  (EXP)
imidacloprid  (ISO)
indometacin  (ISO)
isoprenaline  (ISO)
isotretinoin  (EXP)
ivermectin  (EXP)
ketoconazole  (ISO)
lead(0)  (EXP)
leflunomide  (EXP,ISO)
lenvatinib  (ISO)
linalool  (EXP)
linalyl acetate  (EXP)
lithocholic acid  (ISO)
Mesaconitine  (ISO)
methyl methanesulfonate  (EXP)
mitomycin C  (EXP)
mono(2-ethylhexyl) phthalate  (ISO)
Monobutylphthalate  (ISO)
monosodium L-glutamate  (ISO)
Muraglitazar  (EXP,ISO)
nefazodone  (ISO)
nicotinic acid  (EXP)
nimesulide  (ISO)
nordihydroguaiaretic acid  (ISO)
obeticholic acid  (EXP)
olanzapine  (ISO)
oleic acid  (EXP)
orlistat  (EXP)
oxybenzone  (ISO)
ozone  (ISO)
paclitaxel  (EXP)
paracetamol  (EXP,ISO)
perfluorohexanesulfonic acid  (ISO)
perfluorononanoic acid  (ISO)
perfluorooctane-1-sulfonic acid  (EXP,ISO)
perfluorooctanoic acid  (EXP,ISO)
phenobarbital  (EXP,ISO)
phlorizin  (ISO)
piperonyl butoxide  (ISO)
pirinixic acid  (EXP,ISO)
potassium chloride  (EXP)
pravastatin  (ISO)
prochloraz  (ISO)
quercetin  (EXP)
rac-lactic acid  (EXP)
resveratrol  (ISO)
rotenone  (ISO)
sabinene  (EXP)
SB 431542  (EXP)
sirolimus  (ISO)
sodium arsenite  (EXP,ISO)
Soman  (ISO)
spathulenol  (EXP)
streptozocin  (ISO)
sulforaphane  (ISO)
sunitinib  (EXP)
temozolomide  (EXP)
Tesaglitazar  (EXP,ISO)
tetrachloromethane  (ISO)
thiabendazole  (ISO)
thioacetamide  (ISO)
thiram  (EXP)
titanium dioxide  (ISO)
toosendanin  (EXP)
tributyl phosphate  (EXP)
tributylstannane  (ISO)
trichloroacetic acid  (ISO)
trichloroethene  (ISO)
triphenyl phosphate  (EXP)
Triptolide  (ISO)
triptonide  (ISO)
Tris(2,3-dibromopropyl) phosphate  (EXP)
tris(2-butoxyethyl) phosphate  (EXP)
Tris(2-ethylhexyl) phosphate  (EXP)
troglitazone  (EXP,ISO)
valproic acid  (EXP)
vinclozolin  (ISO)
zaragozic acid A  (ISO)
zearalenone  (ISO)
zinc atom  (ISO)
zinc(0)  (ISO)
zoledronic acid  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component
mitochondrial inner membrane  (IEA,NAS,TAS)
mitochondrion  (HTP,IBA,IDA,IEA)
nucleolus  (IDA)
nucleoplasm  (IDA)

Molecular Function

Phenotype Annotations     Click to see Annotation Detail View

Human Phenotype
Abnormal autonomic nervous system physiology  (IAGP)
Abnormal basal ganglia morphology  (IAGP)
Abnormal brain morphology  (IAGP)
Abnormal foot morphology  (IAGP)
Abnormal myocardium morphology  (IAGP)
Abnormality of neuronal migration  (IAGP)
Abnormality of the musculature  (IAGP)
Abnormality of the nervous system  (IAGP)
Agenesis of corpus callosum  (IAGP)
Antenatal intracerebral hemorrhage  (IAGP)
Apnea  (IAGP)
Arrhythmia  (IAGP)
Arthritis  (IAGP)
Autosomal dominant inheritance  (IAGP)
Autosomal recessive inheritance  (IAGP)
Basal ganglia cysts  (IAGP)
Bulbous nose  (IAGP)
Cardiomegaly  (IAGP)
Cardiomyopathy  (IAGP)
Cataract  (IAGP)
Cerebellar vermis hypoplasia  (IAGP)
Cerebral calcification  (IAGP)
Cerebral edema  (IAGP)
Childhood onset  (IAGP)
Chronic pain  (IAGP)
Cold-induced muscle cramps  (IAGP)
Coma  (IAGP)
Cystic renal dysplasia  (IAGP)
Dandy-Walker malformation  (IAGP)
Death in infancy  (IAGP)
Decreased plasma free carnitine  (IAGP)
Decreased plasma total carnitine  (IAGP)
Decreased serum bicarbonate concentration  (IAGP)
Diarrhea  (IAGP)
Dicarboxylic aciduria  (IAGP)
Dilated cardiomyopathy  (IAGP)
Elbow flexion contracture  (IAGP)
Elevated circulating acylcarnitine concentration  (IAGP)
Elevated circulating alanine aminotransferase concentration  (IAGP)
Elevated circulating aspartate aminotransferase concentration  (IAGP)
Elevated circulating creatine kinase concentration  (IAGP)
Elevated circulating creatinine concentration  (IAGP)
Elevated circulating hepatic transaminase concentration  (IAGP)
Elevated circulating long chain fatty acid concentration  (IAGP)
Encephalopathy  (IAGP)
Enlarged kidney  (IAGP)
Episodic abdominal pain  (IAGP)
Exercise intolerance  (IAGP)
Exercise-induced muscle cramps  (IAGP)
Exercise-induced myalgia  (IAGP)
Feeding difficulties  (IAGP)
Feeding difficulties in infancy  (IAGP)
Fetal onset  (IAGP)
Fever  (IAGP)
Gastrointestinal dysmotility  (IAGP)
Generalized hypotonia  (IAGP)
Genu valgum  (IAGP)
Headache  (IAGP)
Heart block  (IAGP)
Hepatic calcification  (IAGP)
Hepatic failure  (IAGP)
Hepatic steatosis  (IAGP)
Hepatomegaly  (IAGP)
High forehead  (IAGP)
High palate  (IAGP)
High, narrow palate  (IAGP)
Hydrocephalus  (IAGP)
Hydronephrosis  (IAGP)
Hyperammonemia  (IAGP)
Hyperextensibility at elbow  (IAGP)
Hyperextensibility of the finger joints  (IAGP)
Hyperextensible hand joints  (IAGP)
Hyperlipidemia  (IAGP)
Hypoglycemia  (IAGP)
Hypoglycemic encephalopathy  (IAGP)
Hypoketotic hypoglycemia  (IAGP)
Hypoplastic toenails  (IAGP)
Hypotonia  (IAGP)
Inappropriate sinus tachycardia  (IAGP)
Increased circulating lactate dehydrogenase concentration  (IAGP)
Increased muscle lipid content  (IAGP)
Increased total bilirubin  (IAGP)
Infantile onset  (IAGP)
Intermittent painful muscle spasms  (IAGP)
Intracerebral periventricular calcifications  (IAGP)
Knee flexion contracture  (IAGP)
Lethargy  (IAGP)
Lipid accumulation in hepatocytes  (IAGP)
Long fingers  (IAGP)
Long toe  (IAGP)
Long-chain dicarboxylic aciduria  (IAGP)
Low-set ears  (IAGP)
Macrovesicular hepatic steatosis  (IAGP)
Metabolic acidosis  (IAGP)
Microcephaly  (IAGP)
Muscle fiber atrophy  (IAGP)
Muscle spasm  (IAGP)
Muscle stiffness  (IAGP)
Muscle weakness  (IAGP)
Myalgia  (IAGP)
Myoglobinuria  (IAGP)
Myopathic facies  (IAGP)
Myopathy  (IAGP)
Narrow palate  (IAGP)
Nasal congestion  (IAGP)
Neonatal hypotonia  (IAGP)
Neonatal respiratory distress  (IAGP)
Nephropathy  (IAGP)
Nonketotic hypoglycemia  (IAGP)
Oligohydramnios  (IAGP)
Overfolded helix  (IAGP)
Pachygyria  (IAGP)
Pancytopenia  (IAGP)
Pes planus  (IAGP)
Polyarticular arthritis  (IAGP)
Polycystic kidney dysplasia  (IAGP)
Polymicrogyria  (IAGP)
Posteriorly rotated ears  (IAGP)
Prominent forehead  (IAGP)
Red-brown urine  (IAGP)
Reduced tissue carnitine O-palmitoyltransferase 2 activity  (IAGP)
Renal dysplasia  (IAGP)
Renal insufficiency  (IAGP)
Renal tubular epithelial necrosis  (IAGP)
Respiratory arrest  (IAGP)
Respiratory failure  (IAGP)
Respiratory insufficiency  (IAGP)
Rhabdomyolysis  (IAGP)
Seizure  (IAGP)
Sinus tachycardia  (IAGP)
Sloping forehead  (IAGP)
Stage 5 chronic kidney disease  (IAGP)
Tapered finger  (IAGP)
Tapered toe  (IAGP)
Tubulointerstitial nephritis  (IAGP)
Ureteral duplication  (IAGP)
Ventricular hypertrophy  (IAGP)
Ventricular tachycardia  (IAGP)
Ventriculomegaly  (IAGP)
Vomiting  (IAGP)
Wide intermamillary distance  (IAGP)
Young adult onset  (IAGP)
References

References - curated
# Reference Title Reference Citation
1. GOAs Human GO annotations GOA_HUMAN data from the GO Consortium
2. KEGG: Kyoto Encyclopedia of Genes and Genomes KEGG
3. 3-Thia fatty acid treatment, in contrast to eicosapentaenoic acid and starvation, induces gene expression of carnitine palmitoyltransferase-II in rat liver. Madsen L and Berge RK, Lipids. 1999 May;34(5):447-56. doi: 10.1007/s11745-999-0384-6.
4. Mitochondrial 3-hydroxy-3-methylglutaryl coenzyme A synthase and carnitine palmitoyltransferase II as potential control sites for ketogenesis during mitochondrion and peroxisome proliferation. Madsen L, etal., Biochem Pharmacol. 1999 May 1;57(9):1011-9.
5. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
6. SMPDB Annotation Import Pipeline Pipeline to import SMPDB annotations from SMPDB into RGD
7. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
8. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
9. RGD HPO Phenotype Annotation Pipeline RGD automated import pipeline for human HPO-to-gene-to-disease annotations
10. Structural insight into function and regulation of carnitine palmitoyltransferase. Rufer AC, etal., Cell Mol Life Sci. 2009 Aug;66(15):2489-501. Epub 2009 May 9.
11. Molecular characterization of inherited carnitine palmitoyltransferase II deficiency. Taroni F, etal., Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8429-33.
12. A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene. Vladutiu GD, etal., Mol Genet Metab 2000 Jun;70(2):134-41.
13. Effect of Creosote Bush-Derived NDGA on Expression of Genes Involved in Lipid Metabolism in Liver of High-Fructose Fed Rats: Relevance to NDGA Amelioration of Hypertriglyceridemia and Hepatic Steatosis. Zhang H, etal., PLoS One. 2015 Sep 22;10(9):e0138203. doi: 10.1371/journal.pone.0138203. eCollection 2015.
Additional References at PubMed
PMID:1961767   PMID:1988962   PMID:2174799   PMID:7711730   PMID:7892212   PMID:7896283   PMID:8086471   PMID:8125298   PMID:8358442   PMID:8499929   PMID:8651281   PMID:9600456  
PMID:9758712   PMID:10090476   PMID:10607472   PMID:11001805   PMID:11095714   PMID:11257506   PMID:11477613   PMID:11855939   PMID:11994355   PMID:12408750   PMID:12410208   PMID:12477932  
PMID:12707442   PMID:12971426   PMID:14605500   PMID:14615409   PMID:15489334   PMID:15622536   PMID:15642848   PMID:15647998   PMID:15754283   PMID:16054041   PMID:16168441   PMID:16670153  
PMID:16671104   PMID:16710414   PMID:16996287   PMID:17179390   PMID:17651973   PMID:17709715   PMID:17936304   PMID:18024217   PMID:18029348   PMID:18306170   PMID:18363739   PMID:18550408  
PMID:18645163   PMID:18996102   PMID:19362304   PMID:19762733   PMID:19913121   PMID:20186120   PMID:20301431   PMID:20370797   PMID:20538056   PMID:20602615   PMID:20628086   PMID:20810031  
PMID:20877624   PMID:20934285   PMID:20952238   PMID:21277129   PMID:21641254   PMID:21697855   PMID:21873635   PMID:21913903   PMID:22199357   PMID:22493507   PMID:23322164   PMID:23475205  
PMID:23566841   PMID:23969168   PMID:24398345   PMID:24816252   PMID:25335471   PMID:25361188   PMID:25578732   PMID:25781464   PMID:26041663   PMID:26186194   PMID:26344197   PMID:26874509  
PMID:27034144   PMID:27499296   PMID:27502741   PMID:27525900   PMID:28054946   PMID:28380382   PMID:28514442   PMID:30007356   PMID:30097533   PMID:30604089   PMID:31151054   PMID:31201655  
PMID:31280863   PMID:31351739   PMID:31536960   PMID:31599017   PMID:31932471   PMID:32296183   PMID:32628020   PMID:32848104   PMID:32877691   PMID:33207079   PMID:33961781   PMID:34020866  
PMID:34626609   PMID:34709727   PMID:34800366   PMID:35013556   PMID:35108639   PMID:35384245   PMID:35446349   PMID:35545034   PMID:35831314   PMID:36195841   PMID:36215168   PMID:37827155  
PMID:37926998   PMID:37950149   PMID:38395422   PMID:38428407  


Genomics

Comparative Map Data
CPT2
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38153,196,824 - 53,214,197 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl153,196,792 - 53,214,197 (+)EnsemblGRCh38hg38GRCh38
GRCh37153,662,496 - 53,679,869 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36153,434,689 - 53,452,455 (+)NCBINCBI36Build 36hg18NCBI36
Build 34153,374,121 - 53,391,888NCBI
Celera151,949,941 - 51,967,712 (+)NCBICelera
Cytogenetic Map1p32.3NCBI
HuRef151,777,752 - 51,795,523 (+)NCBIHuRef
CHM1_1153,779,095 - 53,796,864 (+)NCBICHM1_1
T2T-CHM13v2.0153,078,266 - 53,095,633 (+)NCBIT2T-CHM13v2.0
Cpt2
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm394107,761,179 - 107,780,786 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl4107,761,178 - 107,780,807 (-)EnsemblGRCm39 Ensembl
GRCm384107,903,982 - 107,923,589 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl4107,903,981 - 107,923,610 (-)EnsemblGRCm38mm10GRCm38
MGSCv374107,576,587 - 107,596,194 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv364107,401,914 - 107,421,466 (-)NCBIMGSCv36mm8
Celera4106,252,864 - 106,272,513 (-)NCBICelera
Cytogenetic Map4C7NCBI
cM Map450.18NCBI
Cpt2
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr85127,893,450 - 127,911,347 (-)NCBIGRCr8
mRatBN7.25122,664,677 - 122,682,126 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl5122,664,677 - 122,682,095 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx5125,284,849 - 125,302,210 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.05127,007,897 - 127,025,259 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.05127,059,205 - 127,076,568 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.05127,505,646 - 127,523,016 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl5127,505,614 - 127,523,089 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.05131,353,542 - 131,370,821 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.45129,007,685 - 129,025,501 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.15129,012,910 - 129,030,727 (-)NCBI
Celera5121,406,314 - 121,423,718 (-)NCBICelera
Cytogenetic Map5q34NCBI
Cpt2
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_0049554645,942,986 - 5,970,345 (-)EnsemblChiLan1.0
ChiLan1.0NW_0049554645,942,986 - 5,970,325 (-)NCBIChiLan1.0ChiLan1.0
CPT2
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v21173,623,572 - 173,641,027 (-)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan11172,764,332 - 172,781,782 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v0152,469,416 - 52,487,166 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.1154,069,334 - 54,086,994 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl154,069,334 - 54,086,994 (+)Ensemblpanpan1.1panPan2
CPT2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1555,718,209 - 55,786,175 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl555,718,510 - 55,744,809 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha555,784,409 - 55,811,033 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0555,907,324 - 55,933,944 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl555,906,033 - 55,933,959 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1555,899,940 - 55,926,541 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0555,791,152 - 55,817,745 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0556,180,213 - 56,206,825 (-)NCBIUU_Cfam_GSD_1.0
Cpt2
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_02440505867,540,611 - 67,558,122 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049365227,856,087 - 7,875,685 (-)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_0049365227,858,172 - 7,875,679 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
CPT2
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl6159,036,422 - 159,061,327 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.16159,038,129 - 159,061,327 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.26146,702,081 - 146,774,794 (-)NCBISscrofa10.2Sscrofa10.2susScr3
CPT2
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.12079,710,638 - 79,728,100 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl2079,706,584 - 79,727,689 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366603337,554,717 - 37,572,175 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Cpt2
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_0046249341,250,956 - 1,271,983 (-)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_0046249341,239,849 - 1,271,993 (-)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in CPT2
848 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
NM_000098.3(CPT2):c.1858T>C (p.Trp620Arg) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003451151]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003451152]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003451150]|Carnitine palmitoyltransferase II deficiency [RCV000530360]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003451153]|Inborn genetic diseases [RCV002527740] Chr1:53213476 [GRCh38]
Chr1:53679148 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.833C>T (p.Ser278Leu) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003451165]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003451166]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002497101]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003451164]|Carnitine palmitoyltransferase II deficiency [RCV000525082]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456090] Chr1:53210507 [GRCh38]
Chr1:53676179 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.984T>A (p.Asp328Glu) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV002535029]|not provided [RCV000722289] Chr1:53210658 [GRCh38]
Chr1:53676330 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.960G>A (p.Ser320=) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV001500528] Chr1:53210634 [GRCh38]
Chr1:53676306 [GRCh37]
Chr1:1p32.3
likely benign
NM_000098.3(CPT2):c.1891C>T (p.Arg631Cys) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000415574]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000009508]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002476950]|Carnitine palmitoyltransferase II deficiency [RCV000202472]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003473062]|not provided [RCV001781211] Chr1:53213509 [GRCh38]
Chr1:53679181 [GRCh37]
Chr1:1p32.3
pathogenic
NM_000098.3(CPT2):c.338C>T (p.Ser113Leu) single nucleotide variant Abnormality of the musculature [RCV001813968]|Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000009510]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000194764]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000515252]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000576571]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001004157]|Carnitine palmitoyltransferase II deficiency [RCV000202499]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003137507]|Inborn genetic diseases [RCV000624845]|Rhabdomyolysis [RCV000662284]|not provided [RCV000185836] Chr1:53202427 [GRCh38]
Chr1:53668099 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity
NM_000098.3(CPT2):c.149C>A (p.Pro50His) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000009511]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000009512]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000762941]|Carnitine palmitoyltransferase II deficiency [RCV000202440]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003473063]|Pancytopenia [RCV000735345]|not provided [RCV000440440] Chr1:53197092 [GRCh38]
Chr1:53662764 [GRCh37]
Chr1:1p32.3
pathogenic
NM_000098.3(CPT2):c.1657G>A (p.Asp553Asn) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000009513]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000675130] Chr1:53213275 [GRCh38]
Chr1:53678947 [GRCh37]
Chr1:1p32.3
pathogenic|uncertain significance
NM_000098.3(CPT2):c.1883A>C (p.Tyr628Ser) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000415611]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000009514]|Carnitine palmitoyltransferase II deficiency [RCV000202449] Chr1:53213501 [GRCh38]
Chr1:53679173 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic|not provided
NM_000098.3(CPT2):c.520G>A (p.Glu174Lys) single nucleotide variant Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000009516]|Carnitine palmitoyltransferase II deficiency [RCV000202437]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003473064] Chr1:53210194 [GRCh38]
Chr1:53675866 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic
NM_000098.3(CPT2):c.1148T>A (p.Phe383Tyr) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000009518]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000411002]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000009517]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000762943]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001004159]|Carnitine palmitoyltransferase II deficiency [RCV000202462]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003473065]|Seizure [RCV001270097] Chr1:53210822 [GRCh38]
Chr1:53676494 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity
NM_000098.3(CPT2):c.1507C>T (p.Arg503Cys) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000009519]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001004160]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002490348]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003450624]|Carnitine palmitoyltransferase II deficiency [RCV000202513]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003473066]|not provided [RCV003317032] Chr1:53211181 [GRCh38]
Chr1:53676853 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic
CPT2, 1-BP INS/25-BP DEL, NT534 indel Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000009523] Chr1:1p32 pathogenic
NM_000098.3(CPT2):c.234-1G>A single nucleotide variant Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000009524] Chr1:53202322 [GRCh38]
Chr1:53667994 [GRCh37]
Chr1:1p32.3
pathogenic
CPT2, 11-BP DUP, NT997 duplication Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000009525] Chr1:1p32 pathogenic
NM_000098.3(CPT2):c.680C>T (p.Pro227Leu) single nucleotide variant CPT2-related disorder [RCV003934818]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000009526]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000576348]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002496314]|Carnitine palmitoyltransferase II deficiency [RCV000202466]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003473067]|not provided [RCV000185840] Chr1:53210354 [GRCh38]
Chr1:53676026 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic|uncertain significance
CPT2, 3-BP DEL/5-BP INS, NT109 indel Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000009527] Chr1:1p32 pathogenic
NM_000098.3(CPT2):c.1360G>T (p.Glu454Ter) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000009528]|Carnitine palmitoyltransferase II deficiency [RCV001851765] Chr1:53211034 [GRCh38]
Chr1:53676706 [GRCh37]
Chr1:1p32.3
pathogenic
NM_000098.3(CPT2):c.638A>G (p.Asp213Gly) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000009529]|Carnitine palmitoyltransferase II deficiency [RCV003581557] Chr1:53210312 [GRCh38]
Chr1:53675984 [GRCh37]
Chr1:1p32.3
pathogenic
NM_000098.3(CPT2):c.359A>G (p.Tyr120Cys) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000409888]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000408956]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000009530]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000762942]|Carnitine palmitoyltransferase II deficiency [RCV000202546]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003473068]|not provided [RCV001781212] Chr1:53210033 [GRCh38]
Chr1:53675705 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity
NM_000098.3(CPT2):c.1080C>T (p.Ile360=) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003451701]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003451702]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002488215]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003451700]|Carnitine palmitoyltransferase II deficiency [RCV001394458]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003451703] Chr1:53210754 [GRCh38]
Chr1:53676426 [GRCh37]
Chr1:1p32.3
likely benign
NM_000098.3(CPT2):c.1654T>C (p.Phe552Leu) single nucleotide variant not provided [RCV000722790] Chr1:53213272 [GRCh38]
Chr1:53678944 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.365C>T (p.Ser122Phe) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000536664]|not provided [RCV001532537]|not specified [RCV000518089] Chr1:53210039 [GRCh38]
Chr1:53675711 [GRCh37]
Chr1:1p32.3
likely benign|uncertain significance
NM_000098.3(CPT2):c.1675C>G (p.Leu559Val) single nucleotide variant not provided [RCV000722483] Chr1:53213293 [GRCh38]
Chr1:53678965 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.1941G>A (p.Met647Ile) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000545256] Chr1:53213559 [GRCh38]
Chr1:53679231 [GRCh37]
Chr1:1p32.3
likely benign|uncertain significance
NM_000098.3(CPT2):c.1718T>G (p.Leu573Arg) single nucleotide variant not provided [RCV000723110] Chr1:53213336 [GRCh38]
Chr1:53679008 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.1679G>A (p.Arg560Gln) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003449550]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003449551]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000672447]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000763963]|Carnitine palmitoyltransferase II deficiency [RCV000527595]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456088]|not provided [RCV003144325] Chr1:53213297 [GRCh38]
Chr1:53678969 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.1806T>C (p.Phe602=) single nucleotide variant Carnitine palmitoyl transferase II deficiency, neonatal form [RCV001449948]|Carnitine palmitoyltransferase II deficiency [RCV001082115]|not provided [RCV000596578]|not specified [RCV001264437] Chr1:53213424 [GRCh38]
Chr1:53679096 [GRCh37]
Chr1:1p32.3
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance
NC_000001.11:g.(?_53200699)_(53200819_?)del deletion Carnitine palmitoyltransferase II deficiency [RCV000544302] Chr1:53200699..53200819 [GRCh38]
Chr1:53666371..53666491 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.932A>G (p.Asn311Ser) single nucleotide variant CPT2-related disorder [RCV003962430]|Carnitine palmitoyltransferase II deficiency [RCV000549753]|not specified [RCV000517266] Chr1:53210606 [GRCh38]
Chr1:53676278 [GRCh37]
Chr1:1p32.3
likely benign|uncertain significance
NM_000098.3(CPT2):c.1372A>C (p.Lys458Gln) single nucleotide variant Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001334222]|Carnitine palmitoyltransferase II deficiency [RCV001085292]|not provided [RCV000521689] Chr1:53211046 [GRCh38]
Chr1:53676718 [GRCh37]
Chr1:1p32.3
likely benign|conflicting interpretations of pathogenicity|uncertain significance
GRCh38/hg38 1p32.3-31.3(chr1:50222546-61618373)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051819]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051819]|See cases [RCV000051819] Chr1:50222546..61618373 [GRCh38]
Chr1:50688218..62084045 [GRCh37]
Chr1:50460805..61856633 [NCBI36]
Chr1:1p32.3-31.3
pathogenic
GRCh38/hg38 1p32.3-31.1(chr1:52595352-76767765)x3 copy number gain See cases [RCV000051822] Chr1:52595352..76767765 [GRCh38]
Chr1:53061024..77233450 [GRCh37]
Chr1:52833612..77006038 [NCBI36]
Chr1:1p32.3-31.1
pathogenic
NM_000098.2(CPT2):c.1680G>A (p.Arg560=) single nucleotide variant Malignant melanoma [RCV000064817] Chr1:53213298 [GRCh38]
Chr1:53678970 [GRCh37]
Chr1:53451558 [NCBI36]
Chr1:1p32.3
not provided
NM_000098.3(CPT2):c.1055T>G (p.Phe352Cys) single nucleotide variant CPT2-related disorder [RCV003982874]|Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003453000]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003453001]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000578014]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003452999]|Carnitine palmitoyltransferase II deficiency [RCV000202443]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456002]|not provided [RCV000444353]|not specified [RCV000078115] Chr1:53210729 [GRCh38]
Chr1:53210729..53210730 [GRCh38]
Chr1:53676401 [GRCh37]
Chr1:53676401..53676402 [GRCh37]
Chr1:1p32.3
likely pathogenic|benign|likely benign|conflicting interpretations of pathogenicity
NM_000098.3(CPT2):c.1102G>A (p.Val368Ile) single nucleotide variant CPT2-related disorder [RCV003974955]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV001533572]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001533571]|Carnitine palmitoyltransferase II deficiency [RCV000202483]|not provided [RCV000711317]|not specified [RCV000078116] Chr1:53210776 [GRCh38]
Chr1:53676448 [GRCh37]
Chr1:1p32.3
benign
NM_000098.3(CPT2):c.1239_1240del (p.Lys414fs) deletion Carnitine palmitoyl transferase II deficiency, myopathic form [RCV002225079]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000576522]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002490673]|Carnitine palmitoyltransferase II deficiency [RCV000202516]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474675]|not provided [RCV000185837] Chr1:53210912..53210913 [GRCh38]
Chr1:53676584..53676585 [GRCh37]
Chr1:1p32.3
pathogenic
NM_000098.3(CPT2):c.1547T>C (p.Phe516Ser) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV001854372]|not provided [RCV000078118] Chr1:53211221 [GRCh38]
Chr1:53676893 [GRCh37]
Chr1:1p32.3
likely pathogenic|uncertain significance
NM_000098.3(CPT2):c.1767G>A (p.Thr589=) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003453003]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003453004]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002498374]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003453002]|Carnitine palmitoyltransferase II deficiency [RCV000553368]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456003]|not provided [RCV003656100]|not specified [RCV000078119] Chr1:53213385 [GRCh38]
Chr1:53679057 [GRCh37]
Chr1:1p32.3
benign|likely benign
NM_000098.3(CPT2):c.1939A>G (p.Met647Val) single nucleotide variant Carnitine palmitoyl transferase II deficiency, neonatal form [RCV001533573]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000578093]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000986323]|Carnitine palmitoyltransferase II deficiency [RCV000202533]|not provided [RCV001811357]|not specified [RCV000078120] Chr1:53213557 [GRCh38]
Chr1:53213557..53213558 [GRCh38]
Chr1:53679229 [GRCh37]
Chr1:53679229..53679230 [GRCh37]
Chr1:1p32.3
benign|likely benign|conflicting interpretations of pathogenicity
NM_000098.3(CPT2):c.341-16T>C single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV002055091]|not provided [RCV000078122] Chr1:53209999 [GRCh38]
Chr1:53675671 [GRCh37]
Chr1:1p32.3
likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_000098.3(CPT2):c.302C>T (p.Ala101Val) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003453055]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003453056]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000986322]|Carnitine palmitoyltransferase II deficiency [RCV000544913]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456004]|not provided [RCV001704048]|not specified [RCV000124603] Chr1:53202391 [GRCh38]
Chr1:53668063 [GRCh37]
Chr1:1p32.3
benign
NM_000098.3(CPT2):c.534_558delinsT (p.Leu178_Ile186delinsPhe) indel CPT2-related disorder [RCV003398720]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV002274921]|Carnitine palmitoyltransferase II deficiency [RCV000202494]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474723]|not provided [RCV000414700] Chr1:53210208..53210232 [GRCh38]
Chr1:53675880..53675904 [GRCh37]
Chr1:1p32.3
pathogenic|conflicting interpretations of pathogenicity|uncertain significance
NM_000098.3(CPT2):c.511C>T (p.Leu171=) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003454456]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003454457]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003454455]|Carnitine palmitoyltransferase II deficiency [RCV000385074]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003454458]|not provided [RCV001706139]|not specified [RCV000178037] Chr1:53210185 [GRCh38]
Chr1:53675857 [GRCh37]
Chr1:1p32.3
benign|likely benign|conflicting interpretations of pathogenicity
NM_000098.3(CPT2):c.143G>A (p.Ser48Asn) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV001348111] Chr1:53197086 [GRCh38]
Chr1:53662758 [GRCh37]
Chr1:1p32.3
uncertain significance
GRCh38/hg38 1p32.3-31.3(chr1:52787503-67339873)x3 copy number gain See cases [RCV000141758] Chr1:52787503..67339873 [GRCh38]
Chr1:53253175..67805556 [GRCh37]
Chr1:53025763..67578144 [NCBI36]
Chr1:1p32.3-31.3
likely pathogenic
NM_000098.3(CPT2):c.1646G>A (p.Gly549Asp) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003453045]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003453046]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003453044]|Carnitine palmitoyltransferase II deficiency [RCV000202475]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003453047]|not provided [RCV000591616] Chr1:53213264 [GRCh38]
Chr1:53678936 [GRCh37]
Chr1:1p32.3
pathogenic|conflicting interpretations of pathogenicity|uncertain significance
NM_000098.3(CPT2):c.983A>G (p.Asp328Gly) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000202505] Chr1:53210657 [GRCh38]
Chr1:53676329 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic|not provided
NM_000098.3(CPT2):c.1925_1937del (p.Lys642fs) deletion Carnitine palmitoyltransferase II deficiency [RCV000202522] Chr1:53213540..53213552 [GRCh38]
Chr1:53679212..53679224 [GRCh37]
Chr1:1p32.3
pathogenic|not provided
NM_000098.3(CPT2):c.1737del (p.Ala578_Tyr579insTer) deletion Carnitine palmitoyltransferase II deficiency [RCV000202525] Chr1:53213355 [GRCh38]
Chr1:53679027 [GRCh37]
Chr1:1p32.3
pathogenic|not provided
NM_000098.3(CPT2):c.1145G>A (p.Arg382Lys) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000202539] Chr1:53210819 [GRCh38]
Chr1:53676491 [GRCh37]
Chr1:1p32.3
pathogenic|not provided
NM_000098.3(CPT2):c.641T>C (p.Met214Thr) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000202541] Chr1:53210315 [GRCh38]
Chr1:53675987 [GRCh37]
Chr1:1p32.3
pathogenic|not provided
NM_000098.3(CPT2):c.452G>A (p.Arg151Gln) single nucleotide variant Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000984253]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002477298]|Carnitine palmitoyltransferase II deficiency [RCV000202567]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474724]|not provided [RCV000492874] Chr1:53210126 [GRCh38]
Chr1:53675798 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic
NM_000098.3(CPT2):c.886C>T (p.Arg296Ter) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003989332]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000169096]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002498726]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV004554716]|Carnitine palmitoyltransferase II deficiency [RCV000539401]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474808]|not provided [RCV000153105] Chr1:53210560 [GRCh38]
Chr1:53676232 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic
NM_000098.3(CPT2):c.953T>G (p.Val318Gly) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003453145]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003453146]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002483326]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003453144]|Carnitine palmitoyltransferase II deficiency [RCV001850089]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003453147]|not provided [RCV000153106] Chr1:53210627 [GRCh38]
Chr1:53676299 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.1634A>C (p.Glu545Ala) single nucleotide variant CPT2-related disorder [RCV003952745]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000669380]|Carnitine palmitoyltransferase II deficiency [RCV001085202]|not provided [RCV000723709] Chr1:53211308 [GRCh38]
Chr1:53676980 [GRCh37]
Chr1:1p32.3
likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_000098.3(CPT2):c.1369A>T (p.Lys457Ter) single nucleotide variant CPT2-related disorder [RCV003947445]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000169067]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000762944]|Carnitine palmitoyltransferase II deficiency [RCV000689502]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474897]|not provided [RCV001567590] Chr1:53211043 [GRCh38]
Chr1:53676715 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic
NM_000098.3(CPT2):c.1348A>T (p.Arg450Ter) single nucleotide variant Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000169371]|Carnitine palmitoyltransferase II deficiency [RCV001850399] Chr1:53211022 [GRCh38]
Chr1:53676694 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic
NM_000098.3(CPT2):c.38del (p.Gly13fs) deletion Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000169434]|Carnitine palmitoyltransferase II deficiency [RCV002515200] Chr1:53196978 [GRCh38]
Chr1:53662650 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic
NM_000098.3(CPT2):c.587C>T (p.Pro196Leu) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003454460]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003454461]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003454459]|Carnitine palmitoyltransferase II deficiency [RCV001345861]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456006]|not provided [RCV000178038] Chr1:53210261 [GRCh38]
Chr1:53675933 [GRCh37]
Chr1:1p32.3
uncertain significance
Single allele indel not provided [RCV000178039] Chr1:53675880..53675904 [GRCh37] uncertain significance
NM_000098.3(CPT2):c.1342T>C (p.Phe448Leu) single nucleotide variant Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001810398]|Carnitine palmitoyltransferase II deficiency [RCV000202478]|not provided [RCV000178040]|not specified [RCV000430397] Chr1:53211016 [GRCh38]
Chr1:53676688 [GRCh37]
Chr1:1p32.3
pathogenic|benign|conflicting interpretations of pathogenicity|uncertain significance|other|not provided
NM_000098.3(CPT2):c.674G>A (p.Arg225His) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV001563785]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV001563784]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001563783]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002478590]|Carnitine palmitoyltransferase II deficiency [RCV001852205]|not provided [RCV000178041] Chr1:53210348 [GRCh38]
Chr1:53676020 [GRCh37]
Chr1:1p32.3
conflicting interpretations of pathogenicity|uncertain significance
NM_000098.3(CPT2):c.1460A>C (p.Glu487Ala) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV001056377]|not provided [RCV000178042] Chr1:53211134 [GRCh38]
Chr1:53676806 [GRCh37]
Chr1:1p32.3
pathogenic|uncertain significance
NM_000098.3(CPT2):c.1336G>A (p.Val446Ile) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000635372] Chr1:53211010 [GRCh38]
Chr1:53676682 [GRCh37]
Chr1:1p32.3
likely benign|uncertain significance
NM_000098.3(CPT2):c.1598T>C (p.Val533Ala) single nucleotide variant CPT2-related disorder [RCV003917702]|Carnitine palmitoyltransferase II deficiency [RCV001080230]|not provided [RCV000711322]|not specified [RCV000185827] Chr1:53211272 [GRCh38]
Chr1:53676944 [GRCh37]
Chr1:1p32.3
benign|likely benign|conflicting interpretations of pathogenicity
NM_000098.3(CPT2):c.1964C>A (p.Ser655Tyr) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV001322809]|Inborn genetic diseases [RCV004020250]|not specified [RCV000185828] Chr1:53213582 [GRCh38]
Chr1:53679254 [GRCh37]
Chr1:1p32.3
likely benign|uncertain significance
NM_000098.2(CPT2):c.1789G>C (p.Val597Leu) single nucleotide variant not specified [RCV000185835] Chr1:53213407 [GRCh38]
Chr1:53679079 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.353A>G (p.Asp118Gly) single nucleotide variant CPT2-related disorder [RCV003947559]|Carnitine palmitoyltransferase II deficiency [RCV001085585]|not provided [RCV000440638]|not specified [RCV001804920] Chr1:53210027 [GRCh38]
Chr1:53675699 [GRCh37]
Chr1:1p32.3
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_000098.3(CPT2):c.852C>T (p.Pro284=) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000404930] Chr1:53210526 [GRCh38]
Chr1:53676198 [GRCh37]
Chr1:1p32.3
conflicting interpretations of pathogenicity|uncertain significance
NM_000098.3(CPT2):c.1158A>C (p.Glu386Asp) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000405294] Chr1:53210832 [GRCh38]
Chr1:53676504 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.370C>T (p.Arg124Ter) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000411770]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000410924]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000409811]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001004158]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002500569]|Carnitine palmitoyltransferase II deficiency [RCV000707179]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474939]|not provided [RCV000185829] Chr1:53210044 [GRCh38]
Chr1:53675716 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic
NM_000098.2(CPT2):c.631C>A (p.Pro211Thr) single nucleotide variant not provided [RCV000185830] Chr1:53210305 [GRCh38]
Chr1:53675977 [GRCh37]
Chr1:1p32.3
likely pathogenic
NM_000098.3(CPT2):c.691C>T (p.Arg231Trp) single nucleotide variant CPT2-related disorder [RCV003927721]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000674663]|Carnitine palmitoyltransferase II deficiency [RCV000796802]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474940]|not provided [RCV001092683]|not specified [RCV003230439] Chr1:53210365 [GRCh38]
Chr1:53676037 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance
NM_000098.3(CPT2):c.1048C>T (p.Arg350Cys) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003454482]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003454483]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003454481]|Carnitine palmitoyltransferase II deficiency [RCV000635369]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003454484]|Inborn genetic diseases [RCV002516964]|not provided [RCV000656840] Chr1:53210722 [GRCh38]
Chr1:53676394 [GRCh37]
Chr1:1p32.3
likely pathogenic|uncertain significance
NM_000098.3(CPT2):c.1511C>T (p.Pro504Leu) single nucleotide variant Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003454485]|Carnitine palmitoyltransferase II deficiency [RCV000778986]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474941]|not provided [RCV003144149] Chr1:53211185 [GRCh38]
Chr1:53676857 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic
NM_000098.3(CPT2):c.1763C>G (p.Ser588Cys) single nucleotide variant CPT2-related disorder [RCV003927722]|Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003454487]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003454488]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003454486]|Carnitine palmitoyltransferase II deficiency [RCV000538455]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456007]|Inborn genetic diseases [RCV002516965]|not provided [RCV003736627]|not specified [RCV000594905] Chr1:53213381 [GRCh38]
Chr1:53679053 [GRCh37]
Chr1:1p32.3
pathogenic|benign|likely benign
NM_000098.3(CPT2):c.719C>T (p.Ala240Val) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV002609003] Chr1:53210393 [GRCh38]
Chr1:53676065 [GRCh37]
Chr1:1p32.3
likely pathogenic|uncertain significance
NM_000098.3(CPT2):c.1578T>C (p.Gly526=) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003449028]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003449029]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002487317]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003449027]|Carnitine palmitoyltransferase II deficiency [RCV000262532]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456066]|not provided [RCV001729515]|not specified [RCV000614451] Chr1:53211252 [GRCh38]
Chr1:53676924 [GRCh37]
Chr1:1p32.3
benign|likely benign|conflicting interpretations of pathogenicity
NM_000098.3(CPT2):c.588T>C (p.Pro196=) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003449025]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003449026]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003449024]|Carnitine palmitoyltransferase II deficiency [RCV000290783]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456065]|not specified [RCV000419277] Chr1:53210262 [GRCh38]
Chr1:53675934 [GRCh37]
Chr1:1p32.3
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance
GRCh37/hg19 1p36.12-12(chr1:20608823-120546301)x3 copy number loss not provided [RCV000762767] Chr1:20608823..120546301 [GRCh37]
Chr1:1p36.12-12
likely benign
NM_000098.3(CPT2):c.1608dup (p.Lys537fs) duplication Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000669311]|Carnitine palmitoyltransferase II deficiency [RCV001215229]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV004568523] Chr1:53211280..53211281 [GRCh38]
Chr1:53676952..53676953 [GRCh37]
Chr1:1p32.3
pathogenic|likely pathogenic
NM_000098.3(CPT2):c.401_404del (p.Phe134fs) deletion Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000670602] Chr1:53210073..53210076 [GRCh38]
Chr1:53675745..53675748 [GRCh37]
Chr1:1p32.3
likely pathogenic
NM_000098.3(CPT2):c.1508G>A (p.Arg503His) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000357481] Chr1:53211182 [GRCh38]
Chr1:53676854 [GRCh37]
Chr1:1p32.3
conflicting interpretations of pathogenicity|uncertain significance
NM_000098.3(CPT2):c.1952T>G (p.Leu651Ter) single nucleotide variant Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000670407] Chr1:53213570 [GRCh38]
Chr1:53679242 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.1375C>T (p.Gln459Ter) single nucleotide variant Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000670434] Chr1:53211049 [GRCh38]
Chr1:53676721 [GRCh37]
Chr1:1p32.3
likely pathogenic
NM_000098.3(CPT2):c.1383G>A (p.Leu461=) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV001503653] Chr1:53211057 [GRCh38]
Chr1:53676729 [GRCh37]
Chr1:1p32.3
likely benign
NM_000098.3(CPT2):c.1335C>T (p.Cys445=) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000311919] Chr1:53211009 [GRCh38]
Chr1:53676681 [GRCh37]
Chr1:1p32.3
likely benign|conflicting interpretations of pathogenicity|uncertain significance
NM_000098.2(CPT2):c.-242G>C single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000273378] Chr1:53196702 [GRCh38]
Chr1:53662374 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.757A>G (p.Ile253Val) single nucleotide variant not specified [RCV000516342] Chr1:53210431 [GRCh38]
Chr1:53676103 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.2(CPT2):c.-285C>A single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000277039] Chr1:53196659 [GRCh38]
Chr1:53662331 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.2(CPT2):c.-461T>C single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000362496] Chr1:53196483 [GRCh38]
Chr1:53662155 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.2(CPT2):c.-477C>T single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000307837] Chr1:53196467 [GRCh38]
Chr1:53662139 [GRCh37]
Chr1:1p32.3
likely benign
NM_000098.2(CPT2):c.-242G>A single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000368164]|not provided [RCV004710789] Chr1:53196702 [GRCh38]
Chr1:53662374 [GRCh37]
Chr1:1p32.3
likely benign
NM_000098.3(CPT2):c.577C>T (p.Arg193Cys) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000635374]|not provided [RCV001508866]|not specified [RCV000305853] Chr1:53210251 [GRCh38]
Chr1:53675923 [GRCh37]
Chr1:1p32.3
likely benign|uncertain significance
NM_000098.3(CPT2):c.-117G>T single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000260538] Chr1:53196827 [GRCh38]
Chr1:53662499 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.853G>A (p.Glu285Lys) single nucleotide variant CPT2-related disorder [RCV003967801]|Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003454830]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003454831]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002502152]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003454829]|Carnitine palmitoyltransferase II deficiency [RCV000813356]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456048]|not provided [RCV000310684] Chr1:53210527 [GRCh38]
Chr1:53676199 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_017887.3(CZIB):c.*462_*464dup duplication Carnitine palmitoyltransferase II deficiency [RCV000268466] Chr1:53214194..53214195 [GRCh38]
Chr1:53679866..53679867 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.1559C>T (p.Pro520Leu) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003454818]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003454819]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003454817]|Carnitine palmitoyltransferase II deficiency [RCV001096808]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456047]|not provided [RCV000333706] Chr1:53211233 [GRCh38]
Chr1:53676905 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.1712C>G (p.Pro571Arg) single nucleotide variant Carnitine palmitoyl transferase II deficiency, neonatal form [RCV002283688] Chr1:53213330 [GRCh38]
Chr1:53679002 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.683A>G (p.Lys228Arg) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000345825] Chr1:53210357 [GRCh38]
Chr1:53676029 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.-101C>A single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000315815] Chr1:53196843 [GRCh38]
Chr1:53662515 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.1438G>A (p.Gly480Arg) single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003449474]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003449475]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000669097]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000763960]|Carnitine palmitoyltransferase II deficiency [RCV000635370]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456084]|Inborn genetic diseases [RCV004023502]|not provided [RCV003488648]|not specified [RCV000517111] Chr1:53211112 [GRCh38]
Chr1:53676784 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.2(CPT2):c.-229G>T single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000319362] Chr1:53196715 [GRCh38]
Chr1:53662387 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.388A>C (p.Asn130His) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000284790] Chr1:53210062 [GRCh38]
Chr1:53675734 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_017887.3(CZIB):c.*453A>G single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000354722]|not provided [RCV004715129] Chr1:53214206 [GRCh38]
Chr1:53679878 [GRCh37]
Chr1:1p32.3
benign
NM_000098.3(CPT2):c.1839G>T (p.Gly613=) single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000551928] Chr1:53213457 [GRCh38]
Chr1:53679129 [GRCh37]
Chr1:1p32.3
likely benign
NM_000098.3(CPT2):c.236A>C (p.Lys79Thr) single nucleotide variant CPT2-related disorder [RCV003403273]|Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003451158]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003451159]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001449651]|Carnitine palmitoyltransferase II deficiency [RCV000530003]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456089]|Genu valgum [RCV000626610]|Inborn genetic diseases [RCV004023832]|not provided [RCV001571245] Chr1:53202325 [GRCh38]
Chr1:53667997 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.*439T>C single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000353884] Chr1:53214034 [GRCh38]
Chr1:53679706 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.2(CPT2):c.-216A>G single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000373970] Chr1:53196728 [GRCh38]
Chr1:53662400 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.2(CPT2):c.-282C>T single nucleotide variant Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003445911]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003445912]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002487316]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003445910]|Carnitine palmitoyltransferase II deficiency [RCV000313432]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003445913] Chr1:53196662 [GRCh38]
Chr1:53662334 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_000098.3(CPT2):c.152+3G>A single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000379295] Chr1:53197098 [GRCh38]
Chr1:53662770 [GRCh37]
Chr1:1p32.3
uncertain significance
NM_017887.3(CZIB):c.*457C>A single nucleotide variant Carnitine palmitoyltransferase II deficiency [RCV000299911] Chr1:53214202 [GRCh38]
Chr1:53679874 [GRCh37]
Chr1:1p32.3
likely benign
NM_000098.3(